An Efficacy Study of GlaxoSmithKline (GSK) Biologicals' Candidate Influenza Vaccine GSK2321138A in Children
Clinical trial NCT01439360 · COMPLETED
Trial details
- NCT number
- NCT01439360
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2014-10-31
- Enrollment
- 12046
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.